Revenue: The sum of all revenue fields included for a company's operating activities.
Sangamo Therapeutics, Inc. (SGMO) had Revenue of $0.58M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$0.58M |
$-34.93M |
|
-- |
|
$0.58M |
|
$36.13M |
|
$-35.55M |
|
$0.46M |
|
$-35.09M |
|
$-35.09M |
|
$-34.93M |
|
$-34.93M |
|
$-34.93M |
|
$-34.93M |
|
$-35.55M |
|
$-33.66M |
|
304.27M |
|
304.27M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$44.08M |
|
$14.79M |
|
$44.57M |
|
$88.64M |
|
$50.12M |
|
-- |
|
$32.27M |
|
$82.40M |
|
$6.24M |
|
$6.24M |
|
$6.24M |
|
322.01M |
|
| Cash Flow Statement Financials | |
$-72.81M |
|
$-0.09M |
|
$55.95M |
|
$43.42M |
|
$30.53M |
|
$-12.89M |
|
$6.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-6119.28% |
|
-6119.28% |
|
-- |
|
-6039.76% |
|
-6012.05% |
|
$-72.89M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.11 |
|
81.02 |
|
-559.51% |
|
-559.51% |
|
-39.41% |
|
-559.51% |
|
$0.02 |
|
$-0.24 |
|
$-0.24 |
|